X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (232) 232
Book Review (86) 86
Newsletter (20) 20
Publication (16) 16
Newspaper Article (6) 6
Conference Proceeding (2) 2
Book Chapter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (178) 178
humans (160) 160
paclitaxel (120) 120
cancer (96) 96
oncology (95) 95
chemotherapy (82) 82
female (76) 76
pharmacology & pharmacy (76) 76
animals (68) 68
paclitaxel poliglumex (66) 66
drug delivery systems (54) 54
care and treatment (53) 53
antineoplastic agents - therapeutic use (48) 48
male (46) 46
paclitaxel - administration & dosage (46) 46
cell lung-cancer (45) 45
lung neoplasms - drug therapy (45) 45
carcinoma, non-small-cell lung - drug therapy (42) 42
drugs (40) 40
mice (38) 38
paclitaxel - analogs & derivatives (38) 38
aged (37) 37
antineoplastic agents - administration & dosage (36) 36
cell line, tumor (35) 35
nanoparticles (35) 35
middle aged (34) 34
paclitaxel - therapeutic use (34) 34
ps 2 patients (34) 34
phase-iii trial (32) 32
antineoplastic combined chemotherapy protocols - therapeutic use (31) 31
neoplasms - drug therapy (31) 31
tumors (31) 31
vehicles (30) 30
polyglutamic acid - analogs & derivatives (29) 29
adult (27) 27
breast-cancer (27) 27
nanomedicine (27) 27
antitumor-activity (26) 26
research (26) 26
treatment outcome (26) 26
antineoplastic agents - chemistry (25) 25
ovarian cancer (25) 25
polymers (25) 25
clinical trials (24) 24
drug-delivery (24) 24
paclitaxel poliglumex ct-2103 (24) 24
phase-i (24) 24
albumin-bound paclitaxel (23) 23
chemistry, multidisciplinary (23) 23
comparing paclitaxel poliglumex (23) 23
in-vitro (23) 23
polyglutamic acid - administration & dosage (23) 23
radiotherapy (23) 23
carboplatin (22) 22
docetaxel (22) 22
drug carriers - chemistry (22) 22
metastatic breast-cancer (22) 22
paclitaxel - chemistry (22) 22
pharmaceutical industry (22) 22
phase-ii trial (22) 22
taxol (22) 22
polymer therapeutics (21) 21
polymers - chemistry (21) 21
taxoids - therapeutic use (21) 21
antineoplastic agents, phytogenic - therapeutic use (20) 20
article (20) 20
solid tumors (20) 20
trial (20) 20
breast cancer (19) 19
carcinoma, non-small-cell lung - pathology (19) 19
clinical trials as topic (19) 19
hematology, oncology and palliative medicine (19) 19
lung neoplasms - pathology (19) 19
nanoscience & nanotechnology (19) 19
ovarian neoplasms - drug therapy (19) 19
polyglutamic acid - therapeutic use (19) 19
drug delivery (18) 18
lung cancer (18) 18
macromolecular therapeutics (18) 18
neoplasm staging (18) 18
polyglutamic acid - chemistry (18) 18
development and progression (17) 17
aged, 80 and over (16) 16
analysis (16) 16
antimitotic agents (16) 16
antineoplastic agents (16) 16
antineoplastic agents - adverse effects (16) 16
antineoplastic agents, phytogenic - administration & dosage (16) 16
ct-2103 (16) 16
drug delivery systems - methods (16) 16
mice, nude (16) 16
tumor (16) 16
xenograft model antitumor assays (16) 16
cisplatin (15) 15
gemcitabine (15) 15
lung cancer, non-small cell (15) 15
pharmacology/toxicology (15) 15
single-agent (15) 15
taxanes (15) 15
temozolomide (15) 15
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Clinical Oncology: Cancer Clinical Trials, ISSN 0277-3732, 2013, Volume 37, Issue 5, pp. 444 - 449
Journal Article
American Journal of Clinical Oncology: Cancer Clinical Trials, ISSN 0277-3732, 02/2012, Volume 35, Issue 1, pp. 64 - 67
Purpose: To evaluate the pathologic complete response (CR) rate and safety of paclitaxel poliglumex (PPX), cisplatin, and concurrent radiation for patients... 
radiation | paclitaxel poliglumex | esophageal cancer | INTERSTITIAL FLUID PRESSURE | SURGERY | TUMORS | DELIVERY | TRIAL | ONCOLOGY | RADIOTHERAPY | PHASE-I | CARCINOMA | ENDOTHELIAL GROWTH-FACTOR | Adenocarcinoma - pathology | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Fatigue - etiology | Male | Polyglutamic Acid - administration & dosage | Esophageal Neoplasms - radiotherapy | Carcinoma, Squamous Cell - radiotherapy | Chemoradiotherapy, Adjuvant | Cisplatin - administration & dosage | Esophageal Neoplasms - pathology | Polyglutamic Acid - analogs & derivatives | Adult | Dose Fractionation | Female | Esophageal Neoplasms - therapy | Paclitaxel - administration & dosage | Adenocarcinoma - radiotherapy | Drug Administration Schedule | Paclitaxel - analogs & derivatives | Carcinoma, Squamous Cell - therapy | Esophagectomy | Paclitaxel - adverse effects | Treatment Outcome | Adenocarcinoma - drug therapy | Esophagitis - etiology | Esophagogastric Junction | Carcinoma, Squamous Cell - drug therapy | Nausea - etiology | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - methods | Cisplatin - adverse effects | Aged | Esophageal Neoplasms - drug therapy | Polyglutamic Acid - adverse effects | Index Medicus
Journal Article
JOURNAL OF CONTROLLED RELEASE, ISSN 0168-3659, 12/2005, Volume 109, Issue 1-3, pp. 120 - 126
Paclitaxel poliglumex (PPX) is an innovative macromolecular taxane designed to increase the therapeutic index of paclitaxel. This large macromolecular... 
THERAPEUTICS | paclitaxel | paclitaxel poliglumex | EPR | cathepsin B | XYOTAX | neutropenia | ADVANTAGES | TUMORS | CHEMISTRY, MULTIDISCIPLINARY | CHEMOTHERAPY | CELL LUNG-CANCER | AGENT | alopecia | TAXOL | CONJUGATE | PHARMACOLOGY & PHARMACY | LEUKEMIA
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 06/2008, Volume 3, Issue 6, pp. 623 - 630
Journal Article
British Journal of Cancer, ISSN 0007-0920, 05/2008, Volume 98, Issue 10, pp. 1608 - 1613
Journal Article
Journal Article
American Journal of Clinical Oncology: Cancer Clinical Trials, ISSN 0277-3732, 08/2006, Volume 29, Issue 4, pp. 376 - 379
Journal Article
Journal Article
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 7/2009, Volume 64, Issue 2, pp. 287 - 295
Journal Article
Journal Article
Anti-Cancer Drugs, ISSN 0959-4973, 04/2010, Volume 21, Issue 4, pp. 433 - 438
Journal Article
International Journal of General Medicine, ISSN 1178-7074, 2011, Volume 4, Issue default, pp. 5 - 11
In Phase I evaluation of CT-2103 (paclitaxel poliglumex), prolongation of prothrombin time (PT) and activated thromboplastin time (aPTT) was observed, without... 
CT-2103 | Poliglumex | Paclitaxel | Cancer | paclitaxel | poliglumex | cancer
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2008, Volume 110, Issue 3, pp. 329 - 335
Abstract Purpose To estimate the maximum tolerated dose (MTD) of paclitaxel poliglumex (PPX) in combination with carboplatin in patients with... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Phase I trial | Carboplatin | Chemotherapy | Paclitaxel poliglumex | Ovarian cancer | paclitaxel poliglumex | CREMOPHOR-FREE | SOLID TUMORS | ovarian cancer | GUIDELINES | chemotherapy | OBSTETRICS & GYNECOLOGY | EVALUATE | PHARMACOKINETICS | CT-2103 | ONCOLOGY | carboplatin | phase I trial | CONJUGATE | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Polyglutamic Acid - administration & dosage | Carboplatin - pharmacokinetics | Paclitaxel - pharmacokinetics | Feasibility Studies | Carboplatin - adverse effects | Polyglutamic Acid - analogs & derivatives | Peritoneal Neoplasms - drug therapy | Polyglutamic Acid - pharmacokinetics | Drug Interactions | Aged, 80 and over | Adult | Female | Ovarian Neoplasms - metabolism | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Fallopian Tube Neoplasms - drug therapy | Paclitaxel - analogs & derivatives | Carboplatin - administration & dosage | Paclitaxel - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Peritoneal Neoplasms - metabolism | Aged | Fallopian Tube Neoplasms - metabolism | Polyglutamic Acid - adverse effects | Cohort Studies | Clinical trials | Care and treatment | Product development | Paclitaxel | Cancer | Index Medicus
Journal Article